Skip to main content

Pharmaceutical Quality Control

June 19, 2024

Recombinant Factor C Methods for Endotoxin Testing: Towards Sustainable Development and Reliable Supply Chain

In 2020, vaccine research received significant attention as researchers were engaged in the race to develop an effective vaccine against SARS-CoV-2 worldwide. More broadly, the entire pharmaceutical industry is experiencing this rapid growth. In this context, supply chain sustainability is crucial. The use of horseshoe crab blood in the quality and safety control process is essential to ensure the safety of injectable and implantable pharmaceutical products. Environmental challenges are key in the debate around the use of traditional Limulus Amebocyte Lysate (LAL) methods in favor of more sustainable methods such as recombinant Factor C (rFC).
Discover More

  • October 11, 2023

    Unlocking the potential of pharmaceutical production whilst elevating patient safety

    Scientific discoveries, however important, are not enough to improve public health. Manufacturing infrastructure and innovation are needed to allow pharmaceutical companies to successfully and safely produce products at scale and make them available to clinicians and their patients.
    Read more

  • July 01, 2022

    The Four Key Benefits of RMM

    Over the past few years, industry leaders are increasingly investing in rapid microbiological methods (RMMs) and have already realized significant gains in detection sensitivity, automation, throughput, and time-to-result.
    Read more

  • March 10, 2022

    How Quality Control Testing Helps Ensure Vaccine Safety

    How Quality Control Testing Helps Ensure Vaccine Safety?
    Read more

  • March 09, 2022

    What Horseshoe Crabs Have to Do with Vaccine Development—and Why It’s a Problem

    What Horseshoe Crabs Have to Do with Vaccine Development—and Why It’s a Problem?
    Read more